Remed Co.,Ltd. (KOSDAQ:302550)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,090.00
+5.00 (0.16%)
At close: Apr 28, 2026
-9.25%
Market Cap 95.50B
Revenue (ttm) 24.50B
Net Income (ttm) 526.20M
Shares Out 30.91M
EPS (ttm) 9.00
PE Ratio 181.50
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 154,883
Average Volume 116,764
Open 3,070.00
Previous Close 3,085.00
Day's Range 3,070.00 - 3,160.00
52-Week Range 2,640.00 - 4,595.00
Beta 0.76
RSI 50.20
Earnings Date May 12, 2026

About Remed

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In a... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2003
Employees 92
Stock Exchange KOSDAQ
Ticker Symbol 302550
Full Company Profile

Financial Performance

In 2025, Remed's revenue was 24.50 billion, a decrease of -4.11% compared to the previous year's 25.55 billion. Earnings were 526.20 million, a decrease of -92.66%.

Financial Statements

News

There is no news available yet.